Table 4. Outcome at follow-up (month 3^rd–6^th) in the two arms (92 patients with IFAT titer> = 80).

Measures of efficacy	Ivermectin	Thiabendazole	p
All criteria fulfilled	32/47 (68.1%)	31/45 (68.9%)	0.93
Patients with partial response1 included	41/47 (87.2%)	40/45 (88.9%)	0.81
Efficacy based on negativization of stool microscopy and/or culture	22/24 (91.7%)	27/27 (100%)	0.22∧

Inference on proportions based on Yates' chi-square test, inference on continuous variables based on Student's T test, unless otherwise specified.

∧: Fisher's exact test.

¹Patients with negative stool and drop of only one antibody titer.